Search for: "Bull v. Bull"
Results 81 - 100
of 3,821
Sorted by Relevance
|
Sort by Date
25 Jul 2014, 9:55 pm
ACI faculty will provide insights into: • PTO Procedures utilization in a Hatch-Waxman scenario: IPR, reissue, and more; • Teva v. [read post]
6 Oct 2019, 9:59 pm
., Inc. v. [read post]
30 Jul 2019, 12:46 pm
In one recent federal civil case, Bostick v. [read post]
14 May 2024, 7:04 pm
LAW & DISORDER Performing Arts Division May 15, 2024 INSIDE THIS ISSUE: • A National Ban on Non-Compete Agreements • Paid v. [read post]
5 Sep 2022, 9:18 am
The conference will offer presentations on the following topics: • Proposed Hatch-Waxman Reform Measures including live audience polling • The Fate of "Skinny Labeling" at the Supreme Court in GSK v Teva • The Relationship between Written Description and Enablement in view of Biogen v Mylan • Patent Eligible Subject Matter after the Supreme Court Denied Cert in American Axle v. [read post]
10 Feb 2018, 9:59 pm
• Impression Products, Inc. v. [read post]
15 Oct 2010, 12:06 pm
In the recent domain name dispute of Red Bull GmbH v. [read post]
11 Aug 2018, 9:08 pm
Abbott • Amgen v. [read post]
24 Jan 2014, 8:53 pm
Court of Appeals for the Federal Circuit • Inter Partes and Post-Grant Reviews (including CBM Patent Reviews) • Derivation and Interference Procedures • Fresenius USA v. [read post]
15 Nov 2013, 9:20 pm
• Current problems with privilege; • "Plausibility" in patent law -- UK case law and EPO jurisprudence; • FRAND after the Huawei v. [read post]
14 Apr 2014, 10:06 am
In Tracey v. [read post]
21 Aug 2012, 12:41 pm
The court reversed course and decided that the ruling should only apply to purebred dogs in Tracey v. [read post]
21 Aug 2012, 12:41 pm
The court reversed course and decided that the ruling should only apply to purebred dogs in Tracey v. [read post]
20 Feb 2015, 8:12 pm
Alice Corp. and Nautilus, Inc. v. [read post]
16 Aug 2010, 7:17 pm
The categories are as follows: • Category I: 0 or 1 points • Category II: 2 or 3 points • Category III: 4 through 6 points • Category IV: 7 through 9 points • Category V: 10 through 12 points • Category VI: 13+ points Irrespective of the offense in question - or the adjustments in base offense level that a judge may choose to make - the criminal history can be critical. [read post]
18 Jun 2013, 9:22 pm
•... [read post]
19 Sep 2014, 4:42 am
• • • Friday’s Endnotes – 09/19/14 was originally posted on Copyhype • • • [read post]
4 Jun 2022, 8:18 pm
ACI faculty will offer presentations on the following topics: • Regulatory and Legislative Developments Impacting the Biopharmaceutical Industry • Satisfying Section 112 Requirements and the Future of Genus Claims • The "Skinny Label" Post-GSK v Tevaregarding Biosimilar Carve-Outs • Litigation Strategies for Challenging Reference Drug Patents in IPRs • The Role of ITC in Biotech Litigation • The… [read post]
14 Apr 2013, 8:39 pm
The conference will consist of the following sessions: • Exelixis and Novartis -- Biopharm Patent Term Adjustment Based on (B) Delay; • New FDA Regulations and Their Effect on Existing and Emerging Technologies; • Cintrifuse: Working with Technology Startups and Developing Cincinnati's Innovation Ecosystem; • University Intellectual Property: The Tech Transfer Perspective; • The Exhaustingly Self-Replicating Seeds: Monsanto… [read post]
12 Jan 2012, 5:19 pm
CHADWICK DAVID DORMAN MOYER v. [read post]
